Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Gains from Investment Securities (2016 - 2025)

Anika Therapeutics (ANIK) has disclosed Gains from Investment Securities for 15 consecutive years, with -$762000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities rose 85.85% to -$762000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$6.1 million, a 34.34% increase, with the full-year FY2025 number at $800000.0, down 61.7% from a year prior.
  • Gains from Investment Securities was -$762000.0 for Q4 2025 at Anika Therapeutics, down from $1.8 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $1.8 million in Q2 2025 to a low of -$11.3 million in Q3 2022.
  • A 5-year average of -$1.1 million and a median of $1000.0 in 2021 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: skyrocketed 8200.0% in 2021, then plummeted 8187.69% in 2024.
  • Anika Therapeutics' Gains from Investment Securities stood at $1.0 million in 2021, then plummeted by 127.52% to -$284000.0 in 2022, then skyrocketed by 77.11% to -$65000.0 in 2023, then tumbled by 8187.69% to -$5.4 million in 2024, then soared by 85.85% to -$762000.0 in 2025.
  • Per Business Quant, the three most recent readings for ANIK's Gains from Investment Securities are -$762000.0 (Q4 2025), $1.8 million (Q2 2025), and -$5.4 million (Q4 2024).